GPT and metabolic dysfunction-associated steatotic liver disease: The North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) guidelines recommend the use of serum ALT levels to screen for NAFLD in children, starting from the age of 9 years (14).